APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,005,000 | +23.6% | 411,471 | -16.1% | 3.07% | +53.4% |
| Q1 2021 | $21,046,000 | -25.0% | 490,471 | 0.0% | 2.00% | -19.2% |
| Q4 2020 | $28,055,000 | +85.4% | 490,471 | -2.2% | 2.48% | +7.7% |
| Q3 2020 | $15,133,000 | -7.6% | 501,584 | 0.0% | 2.30% | -83.1% |
| Q2 2020 | $16,382,000 | +21.9% | 501,584 | 0.0% | 13.62% | +19.0% |
| Q1 2020 | $13,437,000 | -56.1% | 501,584 | -49.8% | 11.45% | -12.8% |
| Q4 2019 | $30,620,000 | +27.1% | 1,000,000 | 0.0% | 13.13% | +14.9% |
| Q3 2019 | $24,090,000 | -4.9% | 1,000,000 | 0.0% | 11.43% | +1.6% |
| Q2 2019 | $25,340,000 | -14.8% | 1,000,000 | -34.5% | 11.24% | -53.3% |
| Q1 2019 | $29,759,000 | +26.0% | 1,526,122 | -14.7% | 24.10% | -61.1% |
| Q4 2018 | $23,611,000 | – | 1,790,102 | – | 62.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |